Goal Navigation, Approach-Oriented Coping, and Adjustment in Young Men with Testicular Cancer.

TitleGoal Navigation, Approach-Oriented Coping, and Adjustment in Young Men with Testicular Cancer.
Publication TypeJournal Article
Year of Publication2016
AuthorsHoyt MA, Gamarel KE, Saigal CS, Stanton AL
JournalAnn Behav Med
Date Published2016 Aug

BACKGROUND: Cancer can challenge important life goals for young adult survivors. Poor goal navigation skills might disrupt self-regulation and interfere with coping efforts, particularly approach-oriented attempts. Two studies are presented that investigated relationships among goal navigation processes, approach-oriented coping, and adjustment (i.e., social, emotional, and functional well-being) in separate samples of young adults with testicular cancer.

METHODS: In study 1, in-depth interviews (N = 21) were analyzed using thematic analysis to understand experiences of goal pursuit following cancer. In study 2, 171 men completed measures of goal navigation, coping, and adjustment to cancer.

RESULTS: In study 1, three prominent themes emerged: goal clarification, goal engagement and disengagement, and responses to disrupted goals. Regression analyses in study 2 revealed that goal navigation skills were positively associated with emotional (B = .35, p < .001), social (B = .24, p < .01), and functional (B = .28, p < .001) well-being, as was approach-oriented coping (B = .22, p < .01; B = .32, p < .001; B = .26, p < .001, respectively). Goal navigation moderated associations between approach-oriented coping and well-being, such that those with low goal navigation ability and low approach-oriented coping reported lower well-being.

CONCLUSIONS: Goal navigation skills and approach-oriented coping have unique and interactive relationships with adjustment to testicular cancer. They likely represent important independent targets for intervention, and goal navigation skills might also buffer the negative consequences of low use of approach-oriented coping.

Alternate JournalAnn Behav Med
PubMed ID26935309
PubMed Central IDPMC4935579
Grant ListL30 CA136998 / CA / NCI NIH HHS / United States
T32 MH015750 / MH / NIMH NIH HHS / United States
T32 MH078788 / MH / NIMH NIH HHS / United States